To determine the effects of has-miR-339-5p expression on tumor progression and metastasis, the patients with lung cancer were divided into two groups based on the mean level of the ratio of miR-339-5p relative expression (carcinoma/NAT) in 60 NSCLCs (mean =0.5249). Here, BRD2 is linked to lung carcinoma.